Concepedia

Publication | Closed Access

Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen–positive chronic hepatitis B

DOI

310

Citations

11

References

2008

Year

Patrick Marcellin, Ting‐Tsung Chang, Seng Gee Lim, William Sievert, Myron J. Tong, Sarah Arterburn, Katyna Borroto–Esoda, David Frederick, Franck Rousseau
Hepatology

Abstract

Treatment with ADV beyond 48 weeks was well tolerated and produced long-term virological, biochemical, serological, and histological improvement.

References

YearCitations

Page 1